Preventing non-insulin-dependent diabetes.

PubWeight™: 6.16‹?› | Rank: Top 1%

🔗 View Article (PMID 7729603)

Published in Diabetes on May 01, 1995

Authors

W C Knowler1, K M Narayan, R L Hanson, R G Nelson, P H Bennett, J Tuomilehto, B Scherstén, D J Pettitt

Author Affiliations

1: National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA.

Articles citing this

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care (1999) 16.79

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials (2009) 2.92

Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79

The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27

Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88

Nonpharmacologic therapy and exercise in the prevention of type 2 diabetes. Diabetes Care (2009) 1.22

Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci U S A (1996) 1.19

A project to reduce the burden of diabetes in the African-American Community: Project DIRECT. J Natl Med Assoc (1998) 1.12

Prevention of type 2 diabetes. BMJ (2001) 1.11

Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol (2012) 1.05

Targeting people with pre-diabetes. BMJ (2002) 1.03

Insulin resistance. BMJ (1996) 1.00

Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study. Diabetes Care (2012) 0.95

The use of population attributable risk to estimate the impact of prevention and early detection of type 2 diabetes on population-wide mortality risk in US males. Health Care Manag Sci (1999) 0.95

A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women. Eur J Epidemiol (2001) 0.94

The diabetes prevention program and its global implications. J Am Soc Nephrol (2003) 0.91

Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins. Am J Physiol Cell Physiol (2012) 0.90

Use of glycated hemoglobin (HbA(1C)) and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population. Indian J Clin Biochem (2008) 0.78

The Effect of Individual and Neighbourhood Socioeconomic Status on Diabetes Mellitus Survival in Working Age Patients in Taiwan. PLoS One (2017) 0.75

Articles by these authors

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95

Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27

Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care (2001) 10.79

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 9.76

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet (1991) 9.57

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet (1997) 9.18

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet (1999) 7.65

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care (2000) 7.41

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation (1992) 7.11

Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet (1988) 7.00

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89

Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr (2000) 6.82

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes (2000) 5.83

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA (1999) 5.76

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40

Early growth and coronary heart disease in later life: longitudinal study. BMJ (2001) 5.25

Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ (1994) 5.22

Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med (1996) 5.17

Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ (1999) 5.17

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia (1999) 5.11

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes (1987) 4.86

Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care (2000) 4.62

Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care (1990) 4.49

The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30

Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23

Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06

Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00

Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99

The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet (2000) 3.92

Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87

Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev (1990) 3.64

Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ (1997) 3.63

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41

Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet (1998) 3.37

The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med (1988) 3.36

A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35

Diabetes mellitus in American (Pima) Indians. Lancet (1971) 3.30

An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet (1998) 3.16

A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15

Diabetes and physical disability among older U.S. adults. Diabetes Care (2000) 3.10

The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10

Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05

Symptoms of chronic bronchitis and the risk of coronary disease. Lancet (1996) 3.03

Identification of a small RNA containing the trypanosome spliced leader: a donor of shared 5' sequences of trypanosomatid mRNAs? Cell (1984) 3.01

Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes (1988) 3.00

Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation (1995) 2.99

Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol (1981) 2.97

Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95

Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products. Infect Immun (2000) 2.92

Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91

Gestational diabetes mellitus. JAMA (2001) 2.90

Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ (1995) 2.89

Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care (1998) 2.88

Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia (2006) 2.85

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (2000) 2.81

Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80

Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80

Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ (1999) 2.78

Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation (1999) 2.78

Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ (2011) 2.77

Screening for type 2 diabetes. Diabetes Care (2000) 2.76

Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73

Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70

Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ (1994) 2.67

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet (1980) 2.64

Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med (1983) 2.60

Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia (2003) 2.60

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59